Weibin Wang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Gene Expression

Circulating Tumor

Top Venues

Cancer gene therapy

Nature communications

Cold Spring Harbor molecular case studies

Peking University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking University Mar 01 2019

China

PI :: Radiation Medicine

Yale University Jul 01 2014 - Jan 31 2019

United States

Postdoc :: Molecular Biophysics and Biochemistry

Publications

Guihui Yu, Yundong Xiong, Zhanzhan Xu, Lei Zhang, Xiao Albert Zhou, Chen Nie, Shiwei Li, Weibin Wang, Xiaoman Li, Jiadong Wang
MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts. Cancer gene therapy (2023)
Tao Zhang, Han Yang, Zenan Zhou, Yongtai Bai, Jiadong Wang, Weibin Wang
Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin. Nature communications 13 (1) (2022)
Meghan R Sullivan, Rohit Prakash, Yashpal Rawal, Weibin Wang, Patrick Sung, Marc R Radke, Scott H Kaufmann, Elizabeth M Swisher, Kara A Bernstein, Maria Jasin
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation. Cold Spring Harbor molecular case studies 7 (2) (2021)
Zhanzhan Xu, Xiaoman Li, Hanxiao Li, Chen Nie, Wanchang Liu, Shiwei Li, Zelin Liu, Weibin Wang, Jiadong Wang
Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA. Oncogene 39 (47) (2020)